Influence of artificial gastric juice composition on bioaccessibility of cobalt- and tungsten-containing powders

International Journal of Hygiene and Environmental Health

Volumn 213, Issue 2, 2010, Pages 107-115

  Stefaniak, Aleksandr B ^a   Abbas Virji, M ^a   Harvey, Christopher J ^a   Sbarra, Deborah C ^a   Day, Gregory A ^a   Hoover, Mark D ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Cemented tungsten carbide; Cobalt; Dissolution; Gastric juice; Ingestion

Indexed keywords

COBALT; TUNGSTEN;

ARTICLE; BIOAVAILABILITY; CHEMISTRY; HUMAN; PARTICLE SIZE; SOLUBILITY; STOMACH JUICE;

BIOLOGICAL AVAILABILITY; COBALT; GASTRIC JUICE; HUMANS; PARTICLE SIZE; SOLUBILITY; TUNGSTEN;

EID: 77649236631     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2009.12.006     Document Type: Article

References (44)

1. Alexander C.S. Cobalt and the heart. Ann. Intern. Med. 70 (1969) 411-413
2. Alexander C.S. Cobalt-beer cardiomyopathy. A clinical and pathological study of twenty-eight cases. Am. J. Med. 53 (1972) 395-417
3. American Society of Testing Materials. D5517-03: A Standard Method of Determining the Solubility of Metals in Art Materials (2003), ASTM International, West Conshohocken, PA
4. Ansoborlo E., Chalabreysse J., Hengé-Napoli M.-H., and Pujol E. In vitro chemical and cellular tests applied to uranium trioxide with different hydration states. Environ. Health Perspect. 97 (1992) 139-143
5. Ansoborlo E., Guilmette R.A., Hoover M.D., Chazel V., Houpert P., and Hengé-Napoli M.-H. Application of in vitro dissolution tests to different uranium compounds and comparison with in vivo data. Rad. Protect. Dosim. 79 (1998) 33-37
6. Ansoborlo E., Hengé-Napoli M.-H., Chazel V., Gibert R., and Guilmette R.A. Review and critical analysis of available in vitro dissolution tests. Health Phys. 77 (1999) 638-645
7. Bish D.L., and Howard S.A. Quantitative phase analysis using the Rietveld method. J. Appl. Crystallogr. 21 (1988) 86-91
8. Brookes K.J.A. Cemented Carbides for Engineers and Tool Users (1983), International Carbide Data, East Barnet, UK pp. 1-19
9. Carson B.L., Ellis H.V., and McCann J.L. Toxicology and Biological Monitoring of Metals in Humans (1986), Lewis Publishers Inc., Chelsea, MI pp. 85
10. Cherrie J.W., Semple S., Saleem A., Hughson G.W., and Philips A. How important is inadvertent ingestion of hazardous substances at work?. Ann. Occup. Hyg. 50 (2006) 693-704
11. Chipera S.J., and Bish D.L. FULLPAT: a full-pattern quantitative analysis program for X-ray powder diffraction using measured and calculated patterns. J. Appl. Crystallogr. 35 (2002) 744-749
12. Christensen J.M., Poulsen O.M., and Thomsen M. A short-term cross-over study on oral administration of soluble and insoluble cobalt compounds: sex differences in biological levels. Int. Arch. Occup. Environ. Health 65 (1993) 233-240
13. Christensen J.M., and Poulsen O.M.A. 1982-1992 surveillance programme on Danish pottery painters. Biological levels and health effects following exposure to soluble or insoluble cobalt compounds in cobalt blue dyes. Sci. Total Environ. 150 (1994) 95-104
14. Day G.A., Virji M.A., and Stefaniak A.B. Characterization of exposures among cemented tungsten carbide workers. Part II: Assessment of surface contamination and skin exposures to cobalt, chromium and nickel. J. Expo. Sci. Environ. Epidemiol. 19 (2009) 423-434
15. Dean J.R., and Ma R. Aproaches to assess the oral bioaccessibility of persistent organic pollutants: a critical review. Chemosphere 68 (2007) 1399-1407
16. Eidson A.F., and Mewhinney J.A. In vitro solubility of uranium yellowcake samples from four uranium mills and the implications for bioassay interpretation. Health Phys. 39 (1980) 893-902
17. Ellickson K.M., Meeker R.J., Gallo M.A., Buckley B.T., and Lioy P.J. Oral bioavailability of lead and arsenic from a NIST standard reference material. Arch. Environ. Contam. Toxicol. 40 (2001) 128-135
18. Finch G.L., Mewhinney J.A., Eidson A.F., Hoover M.D., and Rothenberg S.J. In vitro dissolution characteristics of beryllium oxide and beryllium metal aerosols. J. Aerosol Sci. 19 (1988) 333-342
19. Gibaldi M. Biopharmaceutics and Clinical Pharmacokinetics. 3rd ed. (1984), Lea and Febiger, Philadelphia, PA
20. Hoover M.D., Castorina B.T., Finch G.L., and Rothenberg S.J. Determination of the oxide layer thickness on beryllium metal particles. Am. Ind. Hyg. Assoc. J. 50 (1989) 550-553
21. Inorganic Crystal Structure Database, Copyright 2003-2005 by Fachinformationszentrum (FIZ), Karlsruhe, http://icsdweb.fiz-karlsruhe.de/index.php (last accessed January 26, 2009).
22. Johansson A., Lundborg M., Hellström P.-Å., Camner P., Keyser T.R., Kirton S.A., et al. Effect of iron, cobalt, and chromium dust on rabbit alveolar macrophages: a comparison with the effects of nickel dust. Environ. Res. 21 (1980) 165-176
23. Kanapilly G.M., Raabe O.G., Goh C.H.T., and Chimenti R.A. Measurement of in vitro dissolution of aerosol particles for comparison to in vivo dissolution in the lower respiratory tract after inhalation. Health Phys. 24 (1973) 497-507
24. Keith L.S., Moffett D.B., Rosemond Z.A., and Wohlers D.W. ATSDR evaluation of health effects of tungsten and relevance to public health. Toxicol. Ind. Health 23 (2007) 347-387
25. Kennedy A., Dornan J.D., and King R. Fatal myocardial disease associated with industrial exposure to cobalt. Lancet 1 (1981) 412-414
26. Kraus T., Schramel P., Schaller K.H., Zöbelein P., Weber A., and Angerer J. Exposure assessment in the hard metal manufacturing industry with special regard to tungsten and its compounds. Occup. Environ. Med. 58 (2001) 631-634
27. Lassner E., and Schubert W.-D. Tungsten: Properties, Chemistry, Technology of the Element, Alloys, and Chemical Compounds (1999), Kluwer Academic/Plenum Publishers, New York pp. 86-123
28. Leggett R.W. The biokinetics of inorganic cobalt in the body. Sci. Total Environ. 389 (2008) 259-269
29. Mercer T.T. On the role of particle size in the dissolution of lung burdens. Health Phys. 13 (1967) 1211-1221
30. Morin Y., Têtu A., and Mercier G. Cobalt cardiomyopathy: clinical aspects. Br. Heart J. 33 Suppl. (1971) 175-178
31. Oomen A.G., Hack A., Minekus M., Zeijdner E., Cornelis C., Schoeters G., et al. Comparison of five in vitro digestion models to study the bioaccessibility of soil contaminants. Environ. Sci. Technol. 36 (2002) 3326-3334
32. Rubin C.S., Holmes A.K., Belson M.G., Jones R.L., Flanders W.D., Kieszak S.M., et al. Investigating childhood leukemia in Churchill County, Nevada. Environ. Health Perspect. 115 (2007) 151-157
33. Ruby M.V., Schoof R., Brattin W., Goldade M., Post G., Harnois M., et al. Advances in evaluating the oral bioavailability of inorganics in soil for use in human health risk assessment. Environ. Sci. Technol. 33 (1999) 3697-3705
34. Sheppard P.R., Toepfer P., Schumacher E., Rhodes K., Ridenour G., and Witten M.L. Morphological and chemical characteristics of airborne tungsten particles of Fallon, Nevada. Microsc. Microanal. 13 (2007) 296-303
35. Smith W.B., Wilson R.R., and Harris D.B. A five-stage cyclone system for in situ sampling. Environ. Sci. Technol. 13 (1992) 1387-1392
36. Stefaniak A.B., Day G.A., Hoover M.D., Breysse P.N., and Scripsick R.C. Differences in dissolution behavior in a phagolysosomal simulant fluid for single-component and multi-component materials associated with beryllium sensitization and chronic beryllium disease. Toxicol. In Vitro 20 (2006) 82-95
37. Stefaniak A.B., Day G.A., Harvey C.J., Leonard S.S., Schwegler-Berry D.E., Chipera S.J., et al. Characteristics of dusts encountered during the production of cemented tungsten carbides. Ind. Health 45 (2007) 793-803
38. Stefaniak A.B., Turk G.C., Dickerson R.M., and Hoover M.D. Size-selective poorly soluble particulate reference materials for evaluation of quantitative analytical methods. Anal. Bioanal. Chem. 391 (2008) 2071-2077
39. Stefaniak A.B., Virji M.A., and Day G.A. Characterization of exposures among cemented tungsten carbide workers. Part I: Size-fractionated exposures to airborne cobalt and tungsten particles. J. Expo. Sci. Environ. Epidemiol. 19 (2009) 475-491
40. Stopford W., Turner J., Cappellini D., and Brock T. Bioaccessibility testing of cobalt compounds. J. Environ. Monit. 5 (2003) 675-680
41. Takahashi H., and Koshi K. Solubility and cell toxicity of cobalt, zinc and lead. Ind. Health 19 (1981) 47-59
42. United States Occupational Safety & Health Administration (US OSHA), 2008. Method Number ID-213: Tungsten and cobalt in workplace atmospheres (ICP analysis). http://www.osha.gov/dts/sltc/methods/inorganic/id213/id213.html, (accessed November 13, 2008).
43. Van de Wiele T.R., Oomen A.G., Wragg J., Cave M., Minekus M., Hack A., et al. Comparison of five in vitro digestion models to in vivo experimental results: lead bioaccessibility in the human gastrointestinal tract. J. Environ. Sci. Health A Tox. Hazard. Subst. Environ. Eng. 15 (2007) 1203-1211
44. World Health Organization. Concise International Chemical Assessment Document No. 69: Cobalt and Inorganic Cobalt Compounds (2006), WHO Press, Geneva, Switzerland 13 pp